RHODES JENNIFER J (EVP, CHIEF LEGAL OFFICER, SEC) sold 25.4% of their position (3.84K shares) of ACADIA PHARMACEUTICALS INC on the open market
Open‑market sale worth $82.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/26/2026ACC: 0001568249-26-000005
Officer· EVP, CHIEF LEGAL OFFICER, SEC
Since Mar 2026
-3.84K
Net shares
Net seller
$82.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
7.51K acquired · 11.36K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+7.51K
Price / share
—
Trade value
—
% of position
98.8%
3/24/2026
7.61K→15.12K
Common Stock
Direct
Shares
−3.84K
Price / share
$21.47
Trade value
$82.53K
% of position
25.4%
3/25/2026
15.12K→11.28K
Total
Net shares
+3.67K
Net value
-$82.53K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/24/2026 | M · Option Exercise | +7.51K | — | — | 98.8% | 7.61K | 15.12K |
| Common Stock Direct | 3/25/2026 | S · Sale | −3.84K | $21.47 | $82.53K | 25.4% | 15.12K | 11.28K |
| Total | +3.67K | -$82.53K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
7.51K shares
Shares
−7.51K
Strike price
Held after
22.55K
Exercisable
—
3/24/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock7.51K shares | 3/24/2026 | M · Option Exercise | −7.51K | — | 22.55K |